Paper Details

  1. Home
  2. Paper Details

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Author: HeusPauline, KitchenerHenry C, LawrieTheresa A, Winter-RoachBrett A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Epithelial ovarian cancer is diagnosed in over 200,000 women each year. Early diagnosis is key for successful treatment. Surgery is the primary treatment, and chemotherapy (adjuvant chemotherapy) is often given afterward. While research shows that platinum-based chemotherapy improves overall survival, the best treatment for different groups of women with varying prognoses is still being determined.
Paper Details　
Original Abstract of the Article :
This is the second update of the review first published in the Cochrane Database of Systematic Reviews in 2009, Issue 1. Epithelial ovarian cancer is diagnosed in over 200,000 women worldwide each year. Ten to 20% of women are diagnosed early, when there is still a good possibility of cure. The trea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457737/

データ提供：米国国立医学図書館（NLM）

Improving Treatment for Early Stage Ovarian Cancer

Ovarian cancer is a challenging disease, affecting over 200,000 women globally every year. Early diagnosis is crucial for successful treatment, as it offers a better chance of cure. For women diagnosed with early-stage ovarian cancer, surgery is often followed by chemotherapy – a process known as adjuvant chemotherapy, to eradicate any remaining cancer cells. This is like clearing the path for a camel caravan to safely traverse a desert by removing any obstacles that might lie ahead.

While platinum-based chemotherapy has been shown to improve overall survival, its precise role and optimal use in different patient subgroups remain a topic of ongoing research. This is akin to carefully mapping out a camel caravan's route to ensure its safe and efficient journey.

Tailoring Treatment for Individual Needs

The research highlights the importance of tailoring treatment plans for individual patients based on their specific prognosis. This is like customizing a camel caravan's equipment and supplies based on the terrain and weather conditions of its journey. By carefully considering individual factors, we can improve the effectiveness of treatment and enhance the likelihood of a positive outcome.

Understanding Ovarian Cancer

Ovarian cancer is a complex and challenging disease, but with continued research and a focus on personalized care, we can continue to improve the lives of women affected by this condition. Think of it like a dedicated team of researchers working tirelessly to clear the path for a caravan, ensuring its successful arrival at its destination.

Dr. Camel's Conclusion

Understanding the unique needs of each patient is key to improving treatment outcomes for ovarian cancer. Our research underscores the importance of tailored therapies and continuous investigation to optimize the use of adjuvant chemotherapy and improve the lives of women facing this challenging disease.

Date :
  1. Date Completed 2016-04-28
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

26676202

DOI: Digital Object Identifier

PMC6457737

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.